nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR4—digestive system—Barrett's esophagus	0.0108	0.493	CbGeAlD
Octreotide—Menstrual disorder—Omeprazole—Barrett's esophagus	0.00649	0.00776	CcSEcCtD
Octreotide—Menstrual disorder—Esomeprazole—Barrett's esophagus	0.00649	0.00776	CcSEcCtD
Octreotide—SSTR2—digestive system—Barrett's esophagus	0.00589	0.27	CbGeAlD
Octreotide—Otitis media—Esomeprazole—Barrett's esophagus	0.00569	0.00679	CcSEcCtD
Octreotide—Otitis media—Omeprazole—Barrett's esophagus	0.00569	0.00679	CcSEcCtD
Octreotide—Petechiae—Omeprazole—Barrett's esophagus	0.00538	0.00643	CcSEcCtD
Octreotide—Petechiae—Esomeprazole—Barrett's esophagus	0.00538	0.00643	CcSEcCtD
Octreotide—Arthropathy—Omeprazole—Barrett's esophagus	0.00487	0.00582	CcSEcCtD
Octreotide—Arthropathy—Esomeprazole—Barrett's esophagus	0.00487	0.00582	CcSEcCtD
Octreotide—Hyperbilirubinaemia—Omeprazole—Barrett's esophagus	0.00487	0.00582	CcSEcCtD
Octreotide—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	0.00487	0.00582	CcSEcCtD
Octreotide—SSTR4—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00482	0.0346	CbGpPWpGaD
Octreotide—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.00443	0.00529	CcSEcCtD
Octreotide—Vaginal inflammation—Omeprazole—Barrett's esophagus	0.00443	0.00529	CcSEcCtD
Octreotide—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.00443	0.00529	CcSEcCtD
Octreotide—Vaginal inflammation—Esomeprazole—Barrett's esophagus	0.00443	0.00529	CcSEcCtD
Octreotide—Injection site reaction—Omeprazole—Barrett's esophagus	0.0044	0.00526	CcSEcCtD
Octreotide—Injection site reaction—Esomeprazole—Barrett's esophagus	0.0044	0.00526	CcSEcCtD
Octreotide—Eructation—Omeprazole—Barrett's esophagus	0.00435	0.0052	CcSEcCtD
Octreotide—Eructation—Esomeprazole—Barrett's esophagus	0.00435	0.0052	CcSEcCtD
Octreotide—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00432	0.00517	CcSEcCtD
Octreotide—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00432	0.00517	CcSEcCtD
Octreotide—Cystitis—Omeprazole—Barrett's esophagus	0.00427	0.00511	CcSEcCtD
Octreotide—Cystitis—Esomeprazole—Barrett's esophagus	0.00427	0.00511	CcSEcCtD
Octreotide—Candida infection—Omeprazole—Barrett's esophagus	0.00423	0.00505	CcSEcCtD
Octreotide—Candida infection—Esomeprazole—Barrett's esophagus	0.00423	0.00505	CcSEcCtD
Octreotide—Vaginal infection—Omeprazole—Barrett's esophagus	0.00418	0.00499	CcSEcCtD
Octreotide—Vaginal infection—Esomeprazole—Barrett's esophagus	0.00418	0.00499	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.0041	0.0294	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—SST—Barrett's esophagus	0.00407	0.0292	CbGpPWpGaD
Octreotide—Urine output increased—Omeprazole—Barrett's esophagus	0.004	0.00478	CcSEcCtD
Octreotide—Bladder pain—Omeprazole—Barrett's esophagus	0.004	0.00478	CcSEcCtD
Octreotide—Mouth ulceration—Omeprazole—Barrett's esophagus	0.004	0.00478	CcSEcCtD
Octreotide—Urine output increased—Esomeprazole—Barrett's esophagus	0.004	0.00478	CcSEcCtD
Octreotide—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.004	0.00478	CcSEcCtD
Octreotide—Bladder pain—Esomeprazole—Barrett's esophagus	0.004	0.00478	CcSEcCtD
Octreotide—Gynaecomastia—Omeprazole—Barrett's esophagus	0.00396	0.00473	CcSEcCtD
Octreotide—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.00396	0.00473	CcSEcCtD
Octreotide—Sleep disorder—Esomeprazole—Barrett's esophagus	0.00371	0.00443	CcSEcCtD
Octreotide—Sleep disorder—Omeprazole—Barrett's esophagus	0.00371	0.00443	CcSEcCtD
Octreotide—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00369	0.00441	CcSEcCtD
Octreotide—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00369	0.00441	CcSEcCtD
Octreotide—Polyuria—Esomeprazole—Barrett's esophagus	0.00366	0.00437	CcSEcCtD
Octreotide—Polyuria—Omeprazole—Barrett's esophagus	0.00366	0.00437	CcSEcCtD
Octreotide—SSTR3—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00366	0.0262	CbGpPWpGaD
Octreotide—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00362	0.00433	CcSEcCtD
Octreotide—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00362	0.00433	CcSEcCtD
Octreotide—SSTR1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00351	0.0252	CbGpPWpGaD
Octreotide—Injury—Omeprazole—Barrett's esophagus	0.0035	0.00418	CcSEcCtD
Octreotide—Injury—Esomeprazole—Barrett's esophagus	0.0035	0.00418	CcSEcCtD
Octreotide—Hot flush—Omeprazole—Barrett's esophagus	0.00343	0.0041	CcSEcCtD
Octreotide—Hot flush—Esomeprazole—Barrett's esophagus	0.00343	0.0041	CcSEcCtD
Octreotide—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.0034	0.00407	CcSEcCtD
Octreotide—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.0034	0.00407	CcSEcCtD
Octreotide—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00339	0.00405	CcSEcCtD
Octreotide—Visual disturbance—Omeprazole—Barrett's esophagus	0.00339	0.00405	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.00336	0.0241	CbGpPWpGaD
Octreotide—Arthritis—Omeprazole—Barrett's esophagus	0.00331	0.00395	CcSEcCtD
Octreotide—Arthritis—Esomeprazole—Barrett's esophagus	0.00331	0.00395	CcSEcCtD
Octreotide—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00329	0.00393	CcSEcCtD
Octreotide—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00329	0.00393	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00324	0.0232	CbGpPWpGaD
Octreotide—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00321	0.00384	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00321	0.00384	CcSEcCtD
Octreotide—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00321	0.00384	CcSEcCtD
Octreotide—Pain in extremity—Omeprazole—Barrett's esophagus	0.00321	0.00384	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00321	0.00384	CcSEcCtD
Octreotide—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00321	0.00384	CcSEcCtD
Octreotide—SSTR5—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00311	0.0223	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—SST—Barrett's esophagus	0.00308	0.0221	CbGpPWpGaD
Octreotide—Irritability—Esomeprazole—Barrett's esophagus	0.00307	0.00366	CcSEcCtD
Octreotide—Irritability—Omeprazole—Barrett's esophagus	0.00307	0.00366	CcSEcCtD
Octreotide—SSTR1—G alpha (i) signalling events—SST—Barrett's esophagus	0.00296	0.0212	CbGpPWpGaD
Octreotide—Dry skin—Omeprazole—Barrett's esophagus	0.00294	0.00352	CcSEcCtD
Octreotide—Dry skin—Esomeprazole—Barrett's esophagus	0.00294	0.00352	CcSEcCtD
Octreotide—MPO—IL23-mediated signaling events—RELA—Barrett's esophagus	0.00294	0.0211	CbGpPWpGaD
Octreotide—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00293	0.00351	CcSEcCtD
Octreotide—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00293	0.00351	CcSEcCtD
Octreotide—MPO—epithelium—Barrett's esophagus	0.00293	0.134	CbGeAlD
Octreotide—Cramp muscle—Esomeprazole—Barrett's esophagus	0.00289	0.00346	CcSEcCtD
Octreotide—Cramp muscle—Omeprazole—Barrett's esophagus	0.00289	0.00346	CcSEcCtD
Octreotide—SSTR2—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00287	0.0206	CbGpPWpGaD
Octreotide—Gastritis—Omeprazole—Barrett's esophagus	0.00284	0.0034	CcSEcCtD
Octreotide—Gastritis—Esomeprazole—Barrett's esophagus	0.00284	0.0034	CcSEcCtD
Octreotide—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00283	0.00339	CcSEcCtD
Octreotide—Muscular weakness—Omeprazole—Barrett's esophagus	0.00283	0.00339	CcSEcCtD
Octreotide—Abdominal distension—Esomeprazole—Barrett's esophagus	0.0028	0.00334	CcSEcCtD
Octreotide—Abdominal distension—Omeprazole—Barrett's esophagus	0.0028	0.00334	CcSEcCtD
Octreotide—Influenza—Esomeprazole—Barrett's esophagus	0.00278	0.00332	CcSEcCtD
Octreotide—Influenza—Omeprazole—Barrett's esophagus	0.00278	0.00332	CcSEcCtD
Octreotide—Asthma—Omeprazole—Barrett's esophagus	0.00278	0.00332	CcSEcCtD
Octreotide—Asthma—Esomeprazole—Barrett's esophagus	0.00278	0.00332	CcSEcCtD
Octreotide—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00273	0.00326	CcSEcCtD
Octreotide—Bronchospasm—Omeprazole—Barrett's esophagus	0.00273	0.00326	CcSEcCtD
Octreotide—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00272	0.00325	CcSEcCtD
Octreotide—Pancreatitis—Omeprazole—Barrett's esophagus	0.00272	0.00325	CcSEcCtD
Octreotide—Sweating increased—Omeprazole—Barrett's esophagus	0.0027	0.00323	CcSEcCtD
Octreotide—Sweating increased—Esomeprazole—Barrett's esophagus	0.0027	0.00323	CcSEcCtD
Octreotide—SSTR5—G alpha (i) signalling events—SST—Barrett's esophagus	0.00262	0.0188	CbGpPWpGaD
Octreotide—Dysuria—Omeprazole—Barrett's esophagus	0.0026	0.0031	CcSEcCtD
Octreotide—Dysuria—Esomeprazole—Barrett's esophagus	0.0026	0.0031	CcSEcCtD
Octreotide—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00258	0.00308	CcSEcCtD
Octreotide—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00258	0.00308	CcSEcCtD
Octreotide—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00257	0.00306	CcSEcCtD
Octreotide—Pollakiuria—Omeprazole—Barrett's esophagus	0.00257	0.00306	CcSEcCtD
Octreotide—Weight increased—Esomeprazole—Barrett's esophagus	0.00253	0.00302	CcSEcCtD
Octreotide—Weight increased—Omeprazole—Barrett's esophagus	0.00253	0.00302	CcSEcCtD
Octreotide—Weight decreased—Omeprazole—Barrett's esophagus	0.00251	0.003	CcSEcCtD
Octreotide—Weight decreased—Esomeprazole—Barrett's esophagus	0.00251	0.003	CcSEcCtD
Octreotide—Depression—Omeprazole—Barrett's esophagus	0.00247	0.00295	CcSEcCtD
Octreotide—Depression—Esomeprazole—Barrett's esophagus	0.00247	0.00295	CcSEcCtD
Octreotide—SSTR4—GPCR ligand binding—SST—Barrett's esophagus	0.00246	0.0177	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00245	0.0176	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—SST—Barrett's esophagus	0.00242	0.0174	CbGpPWpGaD
Octreotide—Jaundice—Esomeprazole—Barrett's esophagus	0.00241	0.00288	CcSEcCtD
Octreotide—Jaundice—Omeprazole—Barrett's esophagus	0.00241	0.00288	CcSEcCtD
Octreotide—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00241	0.00288	CcSEcCtD
Octreotide—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00241	0.00288	CcSEcCtD
Octreotide—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00241	0.00288	CcSEcCtD
Octreotide—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00241	0.00288	CcSEcCtD
Octreotide—Haematuria—Esomeprazole—Barrett's esophagus	0.00236	0.00282	CcSEcCtD
Octreotide—Haematuria—Omeprazole—Barrett's esophagus	0.00236	0.00282	CcSEcCtD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00235	0.0169	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00234	0.0028	CcSEcCtD
Octreotide—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00234	0.0028	CcSEcCtD
Octreotide—Epistaxis—Omeprazole—Barrett's esophagus	0.00234	0.00279	CcSEcCtD
Octreotide—Epistaxis—Esomeprazole—Barrett's esophagus	0.00234	0.00279	CcSEcCtD
Octreotide—Sinusitis—Omeprazole—Barrett's esophagus	0.00232	0.00278	CcSEcCtD
Octreotide—Sinusitis—Esomeprazole—Barrett's esophagus	0.00232	0.00278	CcSEcCtD
Octreotide—MPO—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.00227	0.0163	CbGpPWpGaD
Octreotide—Bradycardia—Omeprazole—Barrett's esophagus	0.00226	0.0027	CcSEcCtD
Octreotide—Bradycardia—Esomeprazole—Barrett's esophagus	0.00226	0.0027	CcSEcCtD
Octreotide—MPO—digestive system—Barrett's esophagus	0.00223	0.102	CbGeAlD
Octreotide—Rhinitis—Omeprazole—Barrett's esophagus	0.00223	0.00266	CcSEcCtD
Octreotide—Rhinitis—Esomeprazole—Barrett's esophagus	0.00223	0.00266	CcSEcCtD
Octreotide—Hepatitis—Omeprazole—Barrett's esophagus	0.00222	0.00266	CcSEcCtD
Octreotide—Hepatitis—Esomeprazole—Barrett's esophagus	0.00222	0.00266	CcSEcCtD
Octreotide—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00221	0.00264	CcSEcCtD
Octreotide—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00221	0.00264	CcSEcCtD
Octreotide—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00221	0.00264	CcSEcCtD
Octreotide—Pharyngitis—Omeprazole—Barrett's esophagus	0.00221	0.00264	CcSEcCtD
Octreotide—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00219	0.00262	CcSEcCtD
Octreotide—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00219	0.00262	CcSEcCtD
Octreotide—Visual impairment—Omeprazole—Barrett's esophagus	0.00214	0.00256	CcSEcCtD
Octreotide—Visual impairment—Esomeprazole—Barrett's esophagus	0.00214	0.00256	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00209	0.015	CbGpPWpGaD
Octreotide—Tinnitus—Esomeprazole—Barrett's esophagus	0.00207	0.00248	CcSEcCtD
Octreotide—Tinnitus—Omeprazole—Barrett's esophagus	0.00207	0.00248	CcSEcCtD
Octreotide—Flushing—Omeprazole—Barrett's esophagus	0.00206	0.00246	CcSEcCtD
Octreotide—Flushing—Esomeprazole—Barrett's esophagus	0.00206	0.00246	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—GAST—Barrett's esophagus	0.00203	0.0146	CbGpPWpGaD
Octreotide—Immune system disorder—Omeprazole—Barrett's esophagus	0.00201	0.0024	CcSEcCtD
Octreotide—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00201	0.0024	CcSEcCtD
Octreotide—Alopecia—Esomeprazole—Barrett's esophagus	0.00196	0.00235	CcSEcCtD
Octreotide—Alopecia—Omeprazole—Barrett's esophagus	0.00196	0.00235	CcSEcCtD
Octreotide—Mental disorder—Omeprazole—Barrett's esophagus	0.00195	0.00233	CcSEcCtD
Octreotide—Mental disorder—Esomeprazole—Barrett's esophagus	0.00195	0.00233	CcSEcCtD
Octreotide—Malnutrition—Esomeprazole—Barrett's esophagus	0.00193	0.00231	CcSEcCtD
Octreotide—Malnutrition—Omeprazole—Barrett's esophagus	0.00193	0.00231	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00192	0.0138	CbGpPWpGaD
Octreotide—Flatulence—Omeprazole—Barrett's esophagus	0.00191	0.00228	CcSEcCtD
Octreotide—Flatulence—Esomeprazole—Barrett's esophagus	0.00191	0.00228	CcSEcCtD
Octreotide—Tension—Omeprazole—Barrett's esophagus	0.0019	0.00227	CcSEcCtD
Octreotide—Tension—Esomeprazole—Barrett's esophagus	0.0019	0.00227	CcSEcCtD
Octreotide—SSTR4—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.00188	0.0135	CbGpPWpGaD
Octreotide—Nervousness—Esomeprazole—Barrett's esophagus	0.00188	0.00225	CcSEcCtD
Octreotide—Nervousness—Omeprazole—Barrett's esophagus	0.00188	0.00225	CcSEcCtD
Octreotide—Back pain—Esomeprazole—Barrett's esophagus	0.00187	0.00224	CcSEcCtD
Octreotide—Back pain—Omeprazole—Barrett's esophagus	0.00187	0.00224	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—SST—Barrett's esophagus	0.00187	0.0134	CbGpPWpGaD
Octreotide—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00186	0.00222	CcSEcCtD
Octreotide—Muscle spasms—Omeprazole—Barrett's esophagus	0.00186	0.00222	CcSEcCtD
Octreotide—MPO—Folate Metabolism—RELA—Barrett's esophagus	0.00185	0.0133	CbGpPWpGaD
Octreotide—Desmopressin—PTGS2—Barrett's esophagus	0.00185	1	CrCbGaD
Octreotide—SSTR4—Signaling by GPCR—GAST—Barrett's esophagus	0.00184	0.0132	CbGpPWpGaD
Octreotide—Vision blurred—Omeprazole—Barrett's esophagus	0.00182	0.00218	CcSEcCtD
Octreotide—Vision blurred—Esomeprazole—Barrett's esophagus	0.00182	0.00218	CcSEcCtD
Octreotide—Tremor—Omeprazole—Barrett's esophagus	0.00181	0.00217	CcSEcCtD
Octreotide—Tremor—Esomeprazole—Barrett's esophagus	0.00181	0.00217	CcSEcCtD
Octreotide—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.0018	0.00214	CcSEcCtD
Octreotide—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.0018	0.00214	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—SST—Barrett's esophagus	0.00179	0.0128	CbGpPWpGaD
Octreotide—Anaemia—Omeprazole—Barrett's esophagus	0.00179	0.00214	CcSEcCtD
Octreotide—Anaemia—Esomeprazole—Barrett's esophagus	0.00179	0.00214	CcSEcCtD
Octreotide—Agitation—Omeprazole—Barrett's esophagus	0.00178	0.00212	CcSEcCtD
Octreotide—Agitation—Esomeprazole—Barrett's esophagus	0.00178	0.00212	CcSEcCtD
Octreotide—Malaise—Omeprazole—Barrett's esophagus	0.00174	0.00208	CcSEcCtD
Octreotide—Malaise—Esomeprazole—Barrett's esophagus	0.00174	0.00208	CcSEcCtD
Octreotide—Vertigo—Esomeprazole—Barrett's esophagus	0.00174	0.00208	CcSEcCtD
Octreotide—Vertigo—Omeprazole—Barrett's esophagus	0.00174	0.00208	CcSEcCtD
Octreotide—Palpitations—Esomeprazole—Barrett's esophagus	0.00171	0.00204	CcSEcCtD
Octreotide—Palpitations—Omeprazole—Barrett's esophagus	0.00171	0.00204	CcSEcCtD
Octreotide—Cough—Omeprazole—Barrett's esophagus	0.00169	0.00202	CcSEcCtD
Octreotide—Cough—Esomeprazole—Barrett's esophagus	0.00169	0.00202	CcSEcCtD
Octreotide—Hypertension—Esomeprazole—Barrett's esophagus	0.00167	0.002	CcSEcCtD
Octreotide—Hypertension—Omeprazole—Barrett's esophagus	0.00167	0.002	CcSEcCtD
Octreotide—Chest pain—Omeprazole—Barrett's esophagus	0.00165	0.00197	CcSEcCtD
Octreotide—Myalgia—Omeprazole—Barrett's esophagus	0.00165	0.00197	CcSEcCtD
Octreotide—Arthralgia—Esomeprazole—Barrett's esophagus	0.00165	0.00197	CcSEcCtD
Octreotide—Chest pain—Esomeprazole—Barrett's esophagus	0.00165	0.00197	CcSEcCtD
Octreotide—Myalgia—Esomeprazole—Barrett's esophagus	0.00165	0.00197	CcSEcCtD
Octreotide—Arthralgia—Omeprazole—Barrett's esophagus	0.00165	0.00197	CcSEcCtD
Octreotide—Anxiety—Esomeprazole—Barrett's esophagus	0.00164	0.00196	CcSEcCtD
Octreotide—Anxiety—Omeprazole—Barrett's esophagus	0.00164	0.00196	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00164	0.00195	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00164	0.00195	CcSEcCtD
Octreotide—Discomfort—Omeprazole—Barrett's esophagus	0.00163	0.00194	CcSEcCtD
Octreotide—Discomfort—Esomeprazole—Barrett's esophagus	0.00163	0.00194	CcSEcCtD
Octreotide—Dry mouth—Omeprazole—Barrett's esophagus	0.00161	0.00192	CcSEcCtD
Octreotide—Dry mouth—Esomeprazole—Barrett's esophagus	0.00161	0.00192	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.0016	0.0115	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—SST—Barrett's esophagus	0.00159	0.0114	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.00159	0.0114	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	0.00159	0.0114	CbGpPWpGaD
Octreotide—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00158	0.00189	CcSEcCtD
Octreotide—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00158	0.00189	CcSEcCtD
Octreotide—Infection—Omeprazole—Barrett's esophagus	0.00157	0.00187	CcSEcCtD
Octreotide—Infection—Esomeprazole—Barrett's esophagus	0.00157	0.00187	CcSEcCtD
Octreotide—Shock—Omeprazole—Barrett's esophagus	0.00155	0.00186	CcSEcCtD
Octreotide—Shock—Esomeprazole—Barrett's esophagus	0.00155	0.00186	CcSEcCtD
Octreotide—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00155	0.00185	CcSEcCtD
Octreotide—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00155	0.00185	CcSEcCtD
Octreotide—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00155	0.00185	CcSEcCtD
Octreotide—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00155	0.00185	CcSEcCtD
Octreotide—Tachycardia—Esomeprazole—Barrett's esophagus	0.00154	0.00184	CcSEcCtD
Octreotide—Tachycardia—Omeprazole—Barrett's esophagus	0.00154	0.00184	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—GAST—Barrett's esophagus	0.00154	0.011	CbGpPWpGaD
Octreotide—Skin disorder—Omeprazole—Barrett's esophagus	0.00153	0.00183	CcSEcCtD
Octreotide—Skin disorder—Esomeprazole—Barrett's esophagus	0.00153	0.00183	CcSEcCtD
Octreotide—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00153	0.00182	CcSEcCtD
Octreotide—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00153	0.00182	CcSEcCtD
Octreotide—Anorexia—Esomeprazole—Barrett's esophagus	0.00151	0.0018	CcSEcCtD
Octreotide—Anorexia—Omeprazole—Barrett's esophagus	0.00151	0.0018	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—PTGS2—Barrett's esophagus	0.00148	0.0106	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—GAST—Barrett's esophagus	0.00148	0.0106	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.00147	0.0105	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—SST—Barrett's esophagus	0.00147	0.0105	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00144	0.00172	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00144	0.00172	CcSEcCtD
Octreotide—Insomnia—Omeprazole—Barrett's esophagus	0.00143	0.00171	CcSEcCtD
Octreotide—Insomnia—Esomeprazole—Barrett's esophagus	0.00143	0.00171	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.00143	0.0102	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.00142	0.0102	CbGpPWpGaD
Octreotide—Paraesthesia—Omeprazole—Barrett's esophagus	0.00142	0.00169	CcSEcCtD
Octreotide—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00142	0.00169	CcSEcCtD
Octreotide—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00141	0.00168	CcSEcCtD
Octreotide—Dyspnoea—Omeprazole—Barrett's esophagus	0.00141	0.00168	CcSEcCtD
Octreotide—Somnolence—Omeprazole—Barrett's esophagus	0.0014	0.00168	CcSEcCtD
Octreotide—Somnolence—Esomeprazole—Barrett's esophagus	0.0014	0.00168	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—GAST—Barrett's esophagus	0.0014	0.01	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—SST—Barrett's esophagus	0.00139	0.00999	CbGpPWpGaD
Octreotide—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00139	0.00166	CcSEcCtD
Octreotide—Dyspepsia—Omeprazole—Barrett's esophagus	0.00139	0.00166	CcSEcCtD
Octreotide—Decreased appetite—Omeprazole—Barrett's esophagus	0.00137	0.00164	CcSEcCtD
Octreotide—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00137	0.00164	CcSEcCtD
Octreotide—SSTR1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.00137	0.0098	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00136	0.00163	CcSEcCtD
Octreotide—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00136	0.00163	CcSEcCtD
Octreotide—Fatigue—Esomeprazole—Barrett's esophagus	0.00136	0.00163	CcSEcCtD
Octreotide—Fatigue—Omeprazole—Barrett's esophagus	0.00136	0.00163	CcSEcCtD
Octreotide—Constipation—Omeprazole—Barrett's esophagus	0.00135	0.00161	CcSEcCtD
Octreotide—Pain—Omeprazole—Barrett's esophagus	0.00135	0.00161	CcSEcCtD
Octreotide—Constipation—Esomeprazole—Barrett's esophagus	0.00135	0.00161	CcSEcCtD
Octreotide—Pain—Esomeprazole—Barrett's esophagus	0.00135	0.00161	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—GAST—Barrett's esophagus	0.00134	0.00962	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—GAST—Barrett's esophagus	0.00131	0.00939	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.00131	0.00939	CbGpPWpGaD
Octreotide—Feeling abnormal—Omeprazole—Barrett's esophagus	0.0013	0.00155	CcSEcCtD
Octreotide—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.0013	0.00155	CcSEcCtD
Octreotide—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00129	0.00154	CcSEcCtD
Octreotide—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00129	0.00154	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—SST—Barrett's esophagus	0.00126	0.00907	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.00126	0.00905	CbGpPWpGaD
Octreotide—Urticaria—Omeprazole—Barrett's esophagus	0.00125	0.0015	CcSEcCtD
Octreotide—Urticaria—Esomeprazole—Barrett's esophagus	0.00125	0.0015	CcSEcCtD
Octreotide—Abdominal pain—Omeprazole—Barrett's esophagus	0.00125	0.00149	CcSEcCtD
Octreotide—Body temperature increased—Omeprazole—Barrett's esophagus	0.00125	0.00149	CcSEcCtD
Octreotide—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00125	0.00149	CcSEcCtD
Octreotide—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00125	0.00149	CcSEcCtD
Octreotide—SSTR5—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.00121	0.00869	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—GAST—Barrett's esophagus	0.00121	0.00867	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.0012	0.00862	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—GAST—Barrett's esophagus	0.00119	0.00853	CbGpPWpGaD
Octreotide—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00116	0.00139	CcSEcCtD
Octreotide—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00116	0.00139	CcSEcCtD
Octreotide—SSTR1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.00115	0.00827	CbGpPWpGaD
Octreotide—Asthenia—Esomeprazole—Barrett's esophagus	0.00113	0.00135	CcSEcCtD
Octreotide—Asthenia—Omeprazole—Barrett's esophagus	0.00113	0.00135	CcSEcCtD
Octreotide—SSTR2—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.00112	0.00802	CbGpPWpGaD
Octreotide—Pruritus—Omeprazole—Barrett's esophagus	0.00112	0.00133	CcSEcCtD
Octreotide—Pruritus—Esomeprazole—Barrett's esophagus	0.00112	0.00133	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—GAST—Barrett's esophagus	0.0011	0.00787	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—GAST—Barrett's esophagus	0.00109	0.00782	CbGpPWpGaD
Octreotide—Diarrhoea—Omeprazole—Barrett's esophagus	0.00108	0.00129	CcSEcCtD
Octreotide—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00108	0.00129	CcSEcCtD
Octreotide—MPO—Folate Metabolism—TP53—Barrett's esophagus	0.00107	0.00768	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—SST—Barrett's esophagus	0.00106	0.00757	CbGpPWpGaD
Octreotide—Dizziness—Omeprazole—Barrett's esophagus	0.00104	0.00125	CcSEcCtD
Octreotide—Dizziness—Esomeprazole—Barrett's esophagus	0.00104	0.00125	CcSEcCtD
Octreotide—SSTR5—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.00102	0.00733	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—SST—Barrett's esophagus	0.00101	0.00726	CbGpPWpGaD
Octreotide—Vomiting—Omeprazole—Barrett's esophagus	0.001	0.0012	CcSEcCtD
Octreotide—Vomiting—Esomeprazole—Barrett's esophagus	0.001	0.0012	CcSEcCtD
Octreotide—Rash—Esomeprazole—Barrett's esophagus	0.000996	0.00119	CcSEcCtD
Octreotide—Rash—Omeprazole—Barrett's esophagus	0.000996	0.00119	CcSEcCtD
Octreotide—Dermatitis—Omeprazole—Barrett's esophagus	0.000995	0.00119	CcSEcCtD
Octreotide—Dermatitis—Esomeprazole—Barrett's esophagus	0.000995	0.00119	CcSEcCtD
Octreotide—Headache—Omeprazole—Barrett's esophagus	0.000989	0.00118	CcSEcCtD
Octreotide—Headache—Esomeprazole—Barrett's esophagus	0.000989	0.00118	CcSEcCtD
Octreotide—SSTR4—GPCR ligand binding—CXCL8—Barrett's esophagus	0.00096	0.00689	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—SST—Barrett's esophagus	0.000958	0.00688	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000955	0.00686	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000943	0.00677	CbGpPWpGaD
Octreotide—Nausea—Omeprazole—Barrett's esophagus	0.000938	0.00112	CcSEcCtD
Octreotide—Nausea—Esomeprazole—Barrett's esophagus	0.000938	0.00112	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—SST—Barrett's esophagus	0.000919	0.00659	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000916	0.00657	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—SST—Barrett's esophagus	0.000897	0.00644	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—SST—Barrett's esophagus	0.000828	0.00594	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GAST—Barrett's esophagus	0.000826	0.00593	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—SST—Barrett's esophagus	0.000815	0.00585	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000812	0.00583	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GAST—Barrett's esophagus	0.000792	0.00568	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—SST—Barrett's esophagus	0.000752	0.0054	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.00075	0.00538	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SST—Barrett's esophagus	0.000747	0.00536	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000728	0.00522	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GAST—Barrett's esophagus	0.000702	0.00504	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000697	0.00501	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GAST—Barrett's esophagus	0.000648	0.00465	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000619	0.00444	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000571	0.0041	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SST—Barrett's esophagus	0.000566	0.00406	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SST—Barrett's esophagus	0.000543	0.00389	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000543	0.00389	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000493	0.00354	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SST—Barrett's esophagus	0.000481	0.00345	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SST—Barrett's esophagus	0.000444	0.00319	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000411	0.00295	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APC—Barrett's esophagus	0.000395	0.00284	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000394	0.00283	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000373	0.00268	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000358	0.00257	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.00035	0.00251	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000323	0.00232	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000317	0.00228	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RELA—Barrett's esophagus	0.000309	0.00222	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APC—Barrett's esophagus	0.0003	0.00215	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000293	0.0021	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—Barrett's esophagus	0.000291	0.00209	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APC—Barrett's esophagus	0.000287	0.00206	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APC—Barrett's esophagus	0.000255	0.00183	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APC—Barrett's esophagus	0.000235	0.00169	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RELA—Barrett's esophagus	0.000234	0.00168	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RELA—Barrett's esophagus	0.000224	0.00161	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—Barrett's esophagus	0.000221	0.00158	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—Barrett's esophagus	0.000211	0.00152	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RELA—Barrett's esophagus	0.000199	0.00143	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—Barrett's esophagus	0.000188	0.00135	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RELA—Barrett's esophagus	0.000184	0.00132	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—Barrett's esophagus	0.000179	0.00128	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—Barrett's esophagus	0.000173	0.00124	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—Barrett's esophagus	0.000135	0.000971	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—Barrett's esophagus	0.00013	0.000931	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—Barrett's esophagus	0.000115	0.000826	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—Barrett's esophagus	0.000106	0.000762	CbGpPWpGaD
